Santos Esteban 4
4 · AMGEN INC · Filed May 8, 2025
Insider Transaction Report
Form 4
AMGEN INCAMGN
Santos Esteban
EVP, Operations
Transactions
- Award
Common Stock
2025-05-06+3,327→ 76,367 total - Award
Nqso (Right to Buy)
2025-05-06$270.44/sh+21,510$5,817,164→ 21,510 totalExercise: $270.44From: 2026-05-06Exp: 2035-05-06→ Common Stock (21,510 underlying)
Holdings
- 882.415(indirect: By 401(k))
Common Stock
Footnotes (4)
- [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/6/2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F2]These shares include 373 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- [F3]These shares are acquired under the Company's 401(k) Plan and represent interests in the Company's stock fund as of this filing.
- [F4]These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/6/2026.